Coronavirus S antigen as a marker of effective vaccination
Saved in:
| Date: | 2021 |
|---|---|
| Main Authors: | V. H. Spyrydonov, M. D. Melnychuk |
| Format: | Article |
| Language: | English |
| Published: |
2021
|
| Series: | Reports of the National Academy of Sciences of Ukraine |
| Online Access: | http://jnas.nbuv.gov.ua/article/UJRN-0001248424 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Library portal of National Academy of Sciences of Ukraine | LibNAS |
Institution
Library portal of National Academy of Sciences of Ukraine | LibNASSimilar Items
-
Use of xenogeneic vaccine modified with embryonal nervous tissue antigens in the treatment of B16?melanoma-bearing mice
by: I. M. Voeykova, et al.
Published: (2014) -
Use of xenogeneic vaccine modified with embryonal nervous tissue antigens in the treatment of B16‑melanoma-bearing mice
by: Voeykova, І.М., et al.
Published: (2014) -
Production of bluetongue VP7 virus antigen in Nicotiana tabacum transgenic plants.
by: V. H. Spyrydonov, et al.
Published: (2011) -
Influence of introduction of interleukin-2 and interleukin-12 into experimental marker DNA-vaccine
by: Ya. O. Pokholenko, et al.
Published: (2019) -
Coronavirus scent
by: Ja. M. Khazan
Published: (2020)